摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,10-bis(2'-pyridyl)-3,8-dithiadecane

中文名称
——
中文别名
——
英文名称
1,10-bis(2'-pyridyl)-3,8-dithiadecane
英文别名
2-[2-[4-(2-Pyridin-2-ylethylsulfanyl)butylsulfanyl]ethyl]pyridine
1,10-bis(2'-pyridyl)-3,8-dithiadecane化学式
CAS
——
化学式
C18H24N2S2
mdl
——
分子量
332.534
InChiKey
QWAVKMONUMYYAG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    22
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    76.4
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    Ru(2,6-bis(1-methylbenzimidazol-2-yl)pyridine)Cl3乙醇 、 sodium perchlorate 、 1,10-bis(2'-pyridyl)-3,8-dithiadecane三乙胺 作用下, 以 为溶剂, 反应 24.0h, 以65%的产率得到[Ru(Pdtd)(Me2Bzimpy)](ClO4)2·1.5 EtOH
    参考文献:
    名称:
    具有悬空吡啶配体的Ru(II)硫醚配合物
    摘要:
    摘要通过两种不同的方法,制备了新的Ru(II)聚吡啶基配合物,试图复制以前报道的七配位Ru(II)合成。四齿硫醚,1,8-双(2'-吡啶基)-3,7-二硫代壬烷(Pdto),1,9-双(2'-吡啶基)-3,7-二硫代壬烷(Pdtn)和1,10 -双(2'-吡啶基)-3,8-二硫杂癸烷(Pdtd)通过反应形成[{Ru(L1)} 2(μ-Cl)2] 2+类型的双核钌(II)配合物在双核配合物与三亚胺配体2,6-双(N'-甲基-苯并咪唑基)吡啶(Me 2 Bzimpy)反应后,容易发生对称桥裂解,生成单核配合物。形式为[Ru(L1)(L2)] 2+,其中L1是三个四齿硫醚配体之一,L2是三齿三亚胺。产生单核[Ru(L1)(L2)] 2+配合物的第二种方法涉及Ru(L2)Cl 3与L1在乙醇条件下的反应。在这种单核络合物中,由于Ru(II)的牢固六配位性质,四齿硫醚的吡啶臂之一被迫不配位。使用五齿硫醚1
    DOI:
    10.1016/j.poly.2013.10.001
  • 作为产物:
    描述:
    2-乙烯基吡啶1,4-丁二硫醇乙醇 为溶剂, 反应 48.0h, 以69%的产率得到1,10-bis(2'-pyridyl)-3,8-dithiadecane
    参考文献:
    名称:
    某些苯并咪唑,苯并噻唑和吡啶衍生的螯合剂的合成
    摘要:
    给出了制备新的结合有苯并咪唑,苯并噻唑和吡啶基的线性二齿,四齿和三足七齿配体的程序。该化合物通过其核磁共振,紫外光谱和质谱进行表征。报道了衍生自樟脑酸的手性苯并噻唑的晶体和分子结构。
    DOI:
    10.1002/jhet.5570390225
点击查看最新优质反应信息

文献信息

  • [EN] COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT<br/>[FR] COMPOSITION POUR L'ÉLECTROGALVANISATION D'ALLIAGE D'ÉTAIN ET D'ARGENT COMPRENANT UN AGENT COMPLEXANT
    申请人:BASF SE
    公开号:WO2019185468A1
    公开(公告)日:2019-10-03
    An aqueous composition comprising (a) metal ions comprising tin ions and silver ions and (b) at least one complexing agent of formula (C1) R1-X1-S-X21[D1-X22-]nS-X3-R2, (C2) R1-X1-S-X31-D2-[X32-S-]nX3-R2, (C3) R3-X1-S-X41-[D3-X42-]nS-X3-R4 wherein X1, X3 are independently selected from a linear or branched C1-C12 alkanediyl, which may be unsubstituted or substituted by OH; X21, X22 are independently selected from X1, which may be further substituted by -X5-COOR12, -X5-SO2-O-R12, a C2 to C6 polyoxyalkylene group of formula -(O-CH2- CHR11)z-OH, or a combination thereof, and -X1-NH-CO-X6-CO-NH-X1-; X31, X32 are independently selected from a chemical bond and X1; X41, X42 are independently selected from X1; X5 is a linear or branched Ci to C10 alkyl; X6 is selected from X1 and a divalent 5 or 6 membered aromatic group; R1, R2 are independently selected from a monovalent 5 or 6 membered aromatic N- heterocyclic group comprising one N atom or two N atoms which are separated by at least one C atom, and its derivatives received by N-alkylation with a C1-C6- alkyl group, which may be substituted by --COOR12 or -SO2-O-R12, and which aromatic N- heterocyclic group may optionally further comprise, under the proviso that X21 is substituted by at least one OH, one S atom; R3, R4 are independently selected from a monovalent 5 or 6 membered aliphatic N- heterocyclic group comprising one N atom and one O atom; D1 is independently selected from S, O and NR10-; D2 is (a) a divalent 5 or 6 membered aliphatic heterocyclic ring system comprising 1 or 2 S atoms, or (b) a 5 or 6 membered aromatic heterocyclic ring system comprising at least two N atoms and optionally one or two S atoms; D3 is independently selected from S and NR10-; n is an integer of from 0 to 5; z is an integer from 1 to 50; R10 is selected from H and a linear or branched C1-C12 alkyl; R11 is selected from H and a linear or branched C1 to C6 alkyl; and R12 is selected from R10 and a cation.
    一种性组合物,包括(a)包括离子和银离子属离子和(b)至少一种具有以下结构的络合剂:(C1)R1-X1-S-X21[D1-X22-]nS-X3-R2,(C2)R1-X1-S-X31-D2-[X32-S-]nX3-R2,(C3)R3-X1-S-X41-[D3-X42-]nS-X3-R4,其中X1、X3可独立地选择自线性或支链的C1-C12脂肪二亚基,可以未取代或被OH取代;X21、X22可独立地选择自X1,可以进一步被-X5-COOR12,-X5-SO2-O-R12,具有式-(O-CH2-CHR11)z-OH的C2到C6聚氧烷基,或其组合物取代,以及-X1-NH-CO-X6-CO-NH-X1-;X31、X32可独立地选择自化学键和X1;X41、X42可独立地选择自X1;X5是线性或支链的Ci到C10烷基;X6选择自X1和双价的5或6元芳香族基;R1、R2可独立地选择自包括一个N原子或两个N原子的单价5或6元芳香N-杂环基,通过N-烷基化与C1-C6烷基基团取代的衍生物,可以被--COOR12或-SO2-O-R12取代,该芳香N-杂环基可以选择性地进一步包括,在X21至少被一个OH取代的条件下,一个S原子;R3、R4可独立地选择自包括一个N原子和一个O原子的单价5或6元脂肪N-杂环基;D1可独立地选择自S、O和NR10-;D2是(a)包括1或2个S原子的双价5或6元脂肪杂环环系统,或(b)包括至少两个N原子和可选地一个或两个S原子的5或6元芳香杂环环系统;D3可独立地选择自S和NR10-;n是从0到5的整数;z是从1到50的整数;R10选择自H和线性或支链的C1-C12烷基;R11选择自H和线性或支链的C1到C6烷基;R12选择自R10和阳离子。
  • COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT
    申请人:BASF SE
    公开号:US20210025070A1
    公开(公告)日:2021-01-28
    An aqueous composition comprising (a) metal ions comprising tin ions and silver ions and (b) at least one complexing agent of formula (C1) R 1 —X 1 —S—X 21 [D 1 -X 22 —] n —S—X 3 —R 2 , (C2) R 1 —X 1 —S—X 31 -D 2 -[X 32 —S—] n X 3 —R 2 , (C3) R 3 —X 1 —S—X 41 -[D 3 —X 42 —] n S—X 3 —R 4 wherein X 1 , X 3 are independently selected from a linear or branched C 1 -C 12 alkanediyl, which may be unsubstituted or substituted by OH; X 21 , X 22 are independently selected from X 1 , which may be further substituted by —X 5 —COOR 12 , —X 5 —SO 2 —O—R 12 , a C 2 to C 6 polyoxyalkylene group of formula —(O—CH 2 —CHR 11 ) z —OH, or a combination thereof, and —X 1 —NH—CO—X 6 —CO—NH—X 1 —; X 31 , X 32 are independently selected from a chemical bond and X 1 ; X 41 , X 42 are independently selected from X 1 ; X 5 is a linear or branched Ci to C10 alkyl; X 6 is selected from X 1 and a divalent 5 or 6 membered aromatic group; R 1 , R 2 are independently selected from a monovalent 5 or 6 membered aromatic N-heterocyclic group comprising one N atom or two N atoms which are separated by at least one C atom, and its derivatives received by N-alkylation with a C 1 -C 6 -alkyl group, which may be substituted by —COOR 12 or —SO 2 —O—R 12 , and which aromatic N-heterocyclic group may optionally further comprise, under the proviso that X21 is substituted by at least one OH, one S atom; R 3 , R 4 are independently selected from a monovalent 5 or 6 membered aliphatic N-heterocyclic group comprising one N atom and one O atom; D 1 is independently selected from S, O and NR 10− ; D 2 is (a) a divalent 5 or 6 membered aliphatic heterocyclic ring system comprising 1 or 2 S atoms, or (b) a 5 or 6 membered aromatic heterocyclic ring system comprising at least two N atoms and optionally one or two S atoms; D 3 is independently selected from S and NR 10− ; n is an integer of from 0 to 5; z is an integer from 1 to 50; R 10 is selected from H and a linear or branched C 1 -C 12 alkyl; R 11 is selected from H and a linear or branched C 1 to C 6 alkyl; and R 12 is selected from R10 and a cation.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-